Anna Piekarska

3.9k total citations
111 papers, 1.4k citations indexed

About

Anna Piekarska is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Anna Piekarska has authored 111 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 48 papers in Hepatology and 34 papers in Infectious Diseases. Recurrent topics in Anna Piekarska's work include Hepatitis C virus research (43 papers), Liver Disease Diagnosis and Treatment (36 papers) and Hepatitis B Virus Studies (21 papers). Anna Piekarska is often cited by papers focused on Hepatitis C virus research (43 papers), Liver Disease Diagnosis and Treatment (36 papers) and Hepatitis B Virus Studies (21 papers). Anna Piekarska collaborates with scholars based in Poland, United States and Russia. Anna Piekarska's co-authors include Jacek Namieśnik, Agnieszka Bartoszek, Piotr Konieczka, Barbara Kusznierewicz, Kamila Wójcik, Robert Flisiak, Dorota Zarębska‐Michaluk, Jerzy Jaroszewicz, Krzysztof Tomasiewicz and Małgorzata Pawłowska and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Anna Piekarska

104 papers receiving 1.4k citations

Peers

Anna Piekarska
Xu Zhu China
Alison M. Hill Australia
Jorge Escobedo Mexico
Kerry Schulze United States
Alexandr Parlesak Germany
Rongrong Yang China
Xuejun Zeng China
J. M. Culebras Spain
Ying Wen China
Xu Zhu China
Anna Piekarska
Citations per year, relative to Anna Piekarska Anna Piekarska (= 1×) peers Xu Zhu

Countries citing papers authored by Anna Piekarska

Since Specialization
Citations

This map shows the geographic impact of Anna Piekarska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Piekarska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Piekarska more than expected).

Fields of papers citing papers by Anna Piekarska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Piekarska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Piekarska. The network helps show where Anna Piekarska may publish in the future.

Co-authorship network of co-authors of Anna Piekarska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Piekarska. A scholar is included among the top collaborators of Anna Piekarska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Piekarska. Anna Piekarska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarębska‐Michaluk, Dorota, Michał Kukla, Dorota Dybowska, et al.. (2024). Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices. Pharmacological Reports. 76(5). 1114–1129. 1 indexed citations
2.
Piekarska, Anna, Hanna Berak, Włodzimierz Mazur, et al.. (2024). Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide. Clinical and Experimental Hepatology. 10(3). 165–169.
3.
Zarębska‐Michaluk, Dorota, Olga Tronina, Anna Piekarska, et al.. (2024). Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination. BMC Medicine. 22(1). 486–486. 1 indexed citations
4.
Wójcik, Kamila, Anna Piekarska, & Elżbieta Jabłonowska. (2024). Has COVID-19 Changed the Incidence and Profile of Late Presenters for HIV Infection in Lodz, Polish Reference Centre, Poland?. Journal of Clinical Medicine. 13(14). 4121–4121. 1 indexed citations
5.
Moniuszko‐Malinowska, Anna, Sławomir Pancewicz, Piotr Czupryna, et al.. (2024). Recommendations for the diagnosis and treatment of Lyme Borreliosis of the Polish Society of Epidemiologists and Infectious Disease Physicians. Przeglad Epidemiologiczny. 77(3). 261–278. 5 indexed citations
6.
Flisiak, Robert, Dorota Zarębska‐Michaluk, Hanna Berak, et al.. (2023). Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals. Clinical and Experimental Hepatology. 9(3). 193–201. 4 indexed citations
7.
Tronina, Olga, Dorota Zarębska‐Michaluk, Dorota Dybowska, et al.. (2023). Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens. Viruses. 15(3). 677–677. 3 indexed citations
8.
9.
Tomasiewicz, Krzysztof, Robert Flisiak, Jerzy Jaroszewicz, et al.. (2023). Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023. Clinical and Experimental Hepatology. 9(1). 1–8. 20 indexed citations
10.
Jabłonowska, Elżbieta, Joanna Katarzyna Strzelczyk, Anna Piekarska, & Kamila Wójcik. (2021). Gut Microbiota Diversity in HIV-Infected Patients on Successful Antiretroviral Treatment is Linked to Sexual Preferences but not CD4 Nadir. Archivum Immunologiae et Therapiae Experimentalis. 69(1). 14–14. 5 indexed citations
11.
Piekarska, Anna, Krzysztof Tomasiewicz, Waldemar Halota, et al.. (2020). Searching for the optimal population for hepatitis C virusscreening in Poland. Clinical and Experimental Hepatology. 6(2). 74–76. 7 indexed citations
12.
Wójcik, Kamila, et al.. (2018). The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. Clinical and Experimental Hepatology. 4(1). 1–6. 61 indexed citations
13.
Wójcik, Kamila, Anna Piekarska, & Elżbieta Jabłonowska. (2016). Adherence to antiviral therapy in HIV or HBV-infected patients.. PubMed. 70(1). 27–32, 115. 5 indexed citations
14.
Błaszczyk, Jan, et al.. (2014). Assessment of selected oxygen metabolism in patients with chronic hepatitis C during treatment with pegylated interferon alfa and ribavirin. Postępy Nauk Medycznych. 1 indexed citations
15.
Jabłonowska, Elżbieta, Kamila Wójcik, & Anna Piekarska. (2013). Urine Liver-Type Fatty Acid-Binding Protein and Kidney Injury Molecule-1 in HIV-Infected Patients Receiving Combined Antiretroviral Treatment Based on Tenofovir. AIDS Research and Human Retroviruses. 30(4). 363–369. 11 indexed citations
16.
17.
Piekarska, Anna, et al.. (2010). Biofumigacja jako alternatywna, przyjazna srodowisku technologia ochrony roslin uprawnych. 11–13. 1 indexed citations
18.
Piekarska, Anna, Agnieszka Bartoszek, & Jacek Namieśnik. (2010). Biofumigation as an alternative method of crop protection. 17. 527–547. 8 indexed citations
19.
Pasz‐Walczak, Grażyna, Robert Kubiak, Wojciech Fendler, et al.. (2010). TRAIL protein expression in breast cancer cells correlates with nuclear grade. Archives of Medical Science. 4(4). 545–551. 5 indexed citations
20.
Piekarska, Anna. (2003). Przemoc, kary cielesne i krzywdzenie dzieci. 2(2). 9–19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xu Zhu Breakdown of academic impact, for papers by Alison M. Hill Breakdown of academic impact, for papers by Jorge Escobedo Breakdown of academic impact, for papers by Kerry Schulze Breakdown of academic impact, for papers by Alexandr Parlesak Breakdown of academic impact, for papers by Rongrong Yang Breakdown of academic impact, for papers by Xuejun Zeng Breakdown of academic impact, for papers by J. M. Culebras Breakdown of academic impact, for papers by Ying Wen
Rankless by CCL
2026